News Survey Helps Improve Communication Between Women with MS and Healthcare Providers Survey Helps Improve Communication Between Women with MS and Healthcare Providers by Marta Figueiredo, PhD | November 9, 2017 Share this article: Share article via email Copy article link A national survey in the U.S. revealed that 98% of women newly diagnosed with multiple sclerosis (MS) struggle to discuss important personal concerns with their healthcare team. The survey was conducted online by Wakefield Research on behalf of Teva PharmaceuticalĀ among 1,000 women diagnosed with MS in the last five years.Ā Survey results were used by Teva and the nonprofit group Can Do MSĀ to develop tools to improve communication between women with MS and healthcare professionals upon a disease diagnosis. The survey examined the concerns women face after an MS diagnosis, including: ability to care for themselves (reported by 34% of the women surveyed), ability to care for their current or future children (22%), career and work life demands (17%), ability to have children (15%), and personal relationships (13%). The study also showed that 71% of participants believed talking to their doctor earlier or more openly about those subjects would have helped them in the first six months after their diagnosis. The main reason women cited for not discussing those concerns with a healthcare professional was the discomfort in doing so. āHaving open and candid conversations with your doctor is a cornerstone of great care and disease management, especially when you have a chronic condition like MS,ā Lori Travis, a board-certified neurologist and MS expert practicing at Phoenix Neurological Associates in Arizona, said in a press release. āThe survey findings indicate a strong need for patients and doctors to improve communication and overcome any discomfort there may be around these topics,ā Travis added. Around half of the participants wished they would have covered topics with their healthcare team such as intimacy with a partner (50%), talking about MS with their family (52%), and accepting help from others (51%). Although there is no evidence to suggest that MS patients are less likely to conceive, many also were concerned about not being able to have children. Regarding their careers, 52% of the women said that a more informative conversation at the time of diagnosis would have improved the course of their professional lives. āThe compelling findings from this survey, coming straight from women who have already traveled this road, have helped us get right to the heart of the questions and concerns they wished they asked their healthcare team at the start of their MS journey,ā said Amanda Welch, director of MS marketing at Teva. āThese insights can help deepen our understanding of what women face and how we can offer support during the critical and emotional time immediately after diagnosisā Welch added. The tools created by Teva andĀ Can Do MS to help women and healthcare professionals address relevant topics are availableĀ here. āAt Can Do MS, we are committed to helping people affected by MS increase their education, expand their knowledge and talk openly about what they want now and in the future,ā said Anne Lee Gilbert, director of programs at Can Do MS. Print This Page About the Author Marta Figueiredo, PhD Marta holds a biology degree, a masterās in evolutionary and developmental biology, and a PhD in biomedical sciences from the University of Lisbon, Portugal. She was awarded a research scholarship and a PhD scholarship, and her research focused on the role of several signaling pathways in thymus and parathyroid glands embryonic development. She also previously worked as an assistant professor of an annual one-week embryology course at the University of Lisbonās Faculty of Medicine. Tags Can Do MS, care, children, communication, healthcare, survey, Teva, work
April 24, 2024 News by Lindsey Shapiro, PhD Autoantibodies seen in blood years before MS diagnosis: Study
April 23, 2024 News by Mary Chapman Itās year 10 for MSAAās upcoming Improving Lives Benefit for MS
April 23, 2024 News by Margarida Maia, PhD AAN 2024: Subcutaneous Ocrevus led to nearly no relapses after year